# Agent A — Cross-Verification of Agents B and C

**Agent:** Agent A (Scenario a — Siemens 32ch head coil, lower-20 mode)
**Date:** 2026-07-20

---

## Section 5: Cross-Verification of Agent B (Scenario b — Siemens 20ch Head/Neck)

### 5.1 SNR₀ loss discrepancy: Agent B claims 55-70% in dlPFC vs Agent A's 40-55%

**Verdict: Physically plausible, and I agree with Agent B's directionally higher estimate.**

The physical mechanism is clear: Agent B's 20ch H/N coil has (a) larger housing inner diameter (~28-30 cm vs ~25 cm), (b) fewer crown/dome elements (4-6 vs 12), and (c) greater element-to-brain distance in the vertex/crown region (~15-30 mm vs ~5-15 mm). The receive sensitivity B₁⁻ falls as approximately 1/r², so a doubling of element-to-brain distance alone produces roughly a factor-of-4 reduction in local sensitivity. When combined with √(20/32) ≈ 0.79 channel-count penalty, the additional 15-20 percentage points of SNR₀ loss that Agent B reports are physically well-motivated.

However, I note that Agent B's 55-70% range may be slightly pessimistic for dlPFC specifically (as opposed to vertex/superior parietal). The 20ch H/N's temporal elements at the level of dlPFC (z=+25 to +55) are less disadvantaged than its crown elements, because the temporal elements sit closer to the brain. The dominant loss in dlPFC comes from reduced element count and the larger housing diameter, not from complete absence of nearby elements. I would place my own best estimate for dlPFC at 50-60% loss for scenario (b), which partially overlaps both our ranges.

**Core conclusion:** Agent B's estimate is credible and consistent with the physics. Scenario (b) is genuinely harder on SNR₀ than scenario (a), especially in the dorsal-occipital vertex.

### 5.2 g-factor discrepancy: Agent B claims g=1.25-1.80 at R=3 vs Agent A's 1.15-1.50

**Verdict: Agent B's estimate is physically reasonable for the dorsal/vertex crown region; the lower end (1.25) is plausible for subcortical/temporal regions.**

The g-factor difference follows directly from sensitivity matrix conditioning. In scenario (a), the lower-20 elements are the densest, best-overlapped elements of the 32ch array (the lower ring and mid-ring), which retain good spatial encoding despite the missing crown elements. The g-factor penalty comes primarily from the "blind zone" at the vertex where the missing 12 elements leave a gap in sensitivity coverage. In scenario (b), the 20ch H/N's larger, sparser elements provide intrinsically coarser spatial encoding per element across the *entire* brain, not just the crown.

The full range difference (Agent B's 1.25-1.80 vs my 1.15-1.50) is mathematically consistent: both sets of estimates would converge if we account for the fact that scenario (b)'s worst-case dorsal g (1.80) is worse than scenario (a)'s worst-case dorsal g (1.50), while scenario (b)'s best-case temporal g (1.25) is similar to scenario (a)'s best-case (1.15).

**Implication for protocol design:** I concur with Agent B's recommendation to limit scenario (b) to R=2 maximum, or at most R=3 with dorsal cortex excluded. Scenario (a) is more forgiving — R=3 is viable with appropriate SNR caveats.

### 5.3 Detachable anterior component as within-coil variability

**Verdict: This concern does NOT translate to scenario (a).**

The Siemens 32ch head coil is a monolithic, rigid helmet with no detachable components. All 32 elements are fixed in position; the physical relationship between elements is invariant across scanning sessions. The "lower-20 mode" is purely an electronic channel selection within a fixed physical array. There is no mechanical variability.

Agent B correctly identifies that the 20ch H/N's detachable anterior portion introduces a mechanical degree of freedom that does not exist in scenario (a). If the anterior component is removed for some participants (e.g., claustrophobic patients or children) and not others, this creates three distinct coil states (32ch at Korea, 20ch H/N with anterior at US, 20ch H/N without anterior at US). This is a genuine confound that CAD Lab should document and control if scenario (b) applies.

**Recommendation for scenario (b):** CAD Lab must explicitly log whether the anterior portion was attached for each session. If mixed states exist, treat them as separate coil modes or exclude sessions with the anterior detached.

### 5.4 Noise covariance Ψ: "completely different" vs "partially preserved" claims

**Verdict: Both claims are physically correct for their respective scenarios.**

My scenario (a) claim of "partially preserved Ψ" is justified because the lower-20 elements are the same physical copper loops, with the same overlap geometry, the same preamplifier decoupling network, and the same mutual inductance matrix for the subset of elements that remain active. The noise covariance between any two active elements in the lower-20 mode is *identical* to the corresponding submatrix of the full 32-channel Ψ. The only change is that the rows/columns corresponding to the upper 12 elements are removed. Prewhitening matrices derived from the 32ch Ψ would be valid for the 20-element submatrix.

Agent B's claim that Ψ is "completely different" for the 20ch H/N is equally correct. The 20ch H/N has:
- Different element positions → different mutual inductances
- Different preamplifier input impedance → different noise figure and noise correlation
- Different housing → different sample loading patterns
- Different conductor routing → different parasitic coupling

There is **no element-to-element correspondence** between the two coils' Ψ matrices. They are independent 20×20 matrices with no shared submatrix.

**Physical basis summary:** Scenario (a) preserves Ψ because it's a subset of the same physical array. Scenario (b) replaces Ψ wholesale because it's a different physical product. This difference is irreducible and must drive different harmonization strategies.

### 5.5 Submission to NeuroImage: Agent B rates "Major Revision likely"

**Verdict: I disagree slightly — I would rate scenario (b) as "Major Revision to Possible Reject" without traveling subjects, which is slightly worse than Agent B's assessment.**

Agent B correctly notes that Schmitt 2021 provides direct literature support for the 20ch H/N coil. However, I give this support less weight than Agent B does for three reasons:

1. **Schmitt 2021 is single-site, within-subject.** It validates that the 20ch H/N produces usable fMRI data on a single scanner. It does **not** validate cross-site pooling of data from two different coils. A NeuroImage reviewer will distinguish these two claims sharply.

2. **Schmitt compared 20ch to 64ch, not 32ch.** The channel-count gap in our case (12 channels) is smaller than Schmitt's (44 channels). Critically, Schmitt found that the 64ch coil *sometimes underperformed* the 20ch in deep brain with prescan normalize ON — a paradoxical finding that may not replicate at all for the 32ch vs 20ch comparison because the 32ch lacks the 64ch's extreme sensitivity inhomogeneity.

3. **None of Schmitt's tasks probe emotional processing or executive function — the domains most central to CAD Lab's clinical focus.** A reviewer could argue that the cognitive domain of interest has not been validated for this coil comparison.

I agree with Agent B that (a) traveling subjects, (b) ComBat/SMA validation, (c) power analysis, and (d) pre-registration are all necessary for NeuroImage submission in scenario (b). But I would raise the bar: without traveling subjects, I do not believe NeuroImage would accept scenario (b).

### 5.6 Points where Agent B is overly pessimistic or optimistic

**Overly pessimistic:**

1. **B₁⁺ effects (Section 1.6).** Agent B estimates 1-3% flip-angle variation from the 20ch H/N's housing extending onto the neck. At 3T with body-coil transmit, this is a very small effect that I would classify as negligible (<2%) — consistent with my scenario (a) conclusion. Agent B's cable-trap asymmetry concern is theoretically possible but unlikely to exceed ~1% in practice. The net B₁⁺ differential between coils in scenario (b) remains well below the threshold that would materially affect BOLD contrast or connectivity.

2. **Schmitt 2021 as "helpful" for cross-site pooling (Section 3.2).** Agent B is slightly optimistic about how much Schmitt 2021 helps the cross-site case. While the paper validates the coil, it does not validate pooling. I would downgrade its helpfulness from "Moderate" to "Minimal to Moderate" for the NeuroImage submission argument.

**Overly optimistic:**

1. **ComBat false-positive rate estimate (Section 2.4, 5-10%).** Agent B estimates 5-10% false-positive rate for ComBat at the scenario (b) batch effect size. I believe this is too optimistic. The batch effect in scenario (b) is both larger and more spatially structured than typical site effects. For spatially structured batch effects (which produce region-specific biases — exactly the kind that could mimic or mask clinical group differences), ComBat's false-positive control degrades significantly (Chen et al. 2022, *NeuroImage*). I would estimate 8-15% false-positive rate in the most affected regions (dorsal PFC, occipital) for the R=3 case.

2. **Clinical confound — claustrophobia (Section 3.4).** Agent B correctly flags this concern but may underestimate its severity for an anxiety/depression cohort. If the US site uses the 20ch H/N because it is less claustrophobic (larger bore opening, detachable anterior), then claustrophobic patients may be *systematically assigned* to the US site. This creates a selection bias that is extremely difficult to disentangle from coil effects. Agent B's "more likely" assessment is correct, but I would rate this as a "Critical" concern rather than "High."

### 5.7 Concerns from Agent B that scenario (a) should also adopt

1. **g-factor cannot be assumed from literature alone (MF3).** In scenario (a), I asserted g-factors of 1.15-1.50 at R=3 based on known geometry. However, the actual g-factor depends on the specific GRAPPA kernel size and the boundary condition where inactive elements end and active elements begin. I recommend that scenario (a) also measure or simulate g-factor maps for the lower-20 mode rather than relying purely on literature extrapolation. This is especially important for dorsal regions where the sensitivity gap at the active/inactive boundary may create locally elevated g.

2. **GRAPPA acceleration must be matched between sites (Section 2.3).** Agent B makes an excellent point: if Korea uses R=3 on the 32ch while US uses R=2 on the 20ch (to avoid g-factor issues), the acceleration mismatch creates an additive confound. Scenario (a) faces the same risk if US decides to use R=2 to be conservative while Korea uses R=3. My scenario (a) analysis did not emphasize this sufficiently. **Recommendation: all sites should use the same GRAPPA factor.** If they must differ, model the RNI (residual noise index) explicitly.

---

## Section 6: Cross-Verification of Agent C (Scenario c — Other Vendor 20ch)

### 6.1 SNR₀ uncertainty of ±40-60% — is this justified?

**Verdict: As an MRI physicist, I agree with Agent C's assessment. If anything, ±40-60% may be conservative for certain brain regions.**

The SNR₀ expression SNR₀ ∝ √N · B₁⁻(x) / √R_total is vendor-dependent through every term, and in scenario (c), no single term is constrained by shared hardware:

- **√N factor**: 20 vs 32 channels gives a floor of 0.79, but this is the *best-case* bound. Actual SNR could be lower if element efficiency differs.
- **B₁⁻ sensitivity**: Depends on element geometry, size, proximity to brain, and loading. A GE AIR flexible coil may achieve 2-5 mm closer proximity for cortical regions (potential 10-20% improvement over the rigid Siemens helmet), while a Philips dStream coil's in-coil ADC eliminates cable loss (~0.5-1.5 dB). These gains could move the SNR₀ ratio toward 0.85-0.90 for some regions. Conversely, a poorly designed 20ch with suboptimal element sizing could produce SNR₀ as low as 0.50-0.60.
- **Noise figure**: Siemens, GE, and Philips preamp/ADC architectures differ fundamentally. The net noise figure difference is unbounded without vendor-specific data.

The ±40-60% range is not a formal statistical confidence interval — it is a physically motivated plausible range given the complete absence of direct cross-vendor 20ch comparisons. I cannot tighten it without empirical data. **This is the single strongest argument against proceeding with scenario (c) without traveling subjects.**

### 6.2 B₁⁺ differences of 5-15% across vendors — should scenario (a) add this caution?

**Verdict: Yes — I should add a moderate B₁⁺ caveat to scenario (a)'s "negligible B₁⁺" conclusion.**

My scenario (a) analysis assumed the same Siemens body coil at both sites, giving B₁⁺ < 2% and justifiably negligible. However, Agent C correctly points out that **if the two sites have different Siemens scanner models** (e.g., Prisma vs Skyra vs Vida), the body coils may differ even within the same vendor. Different Siemens body coil generations have different birdcage geometries, different Q, and different tuning, producing measurable B₁⁺ differences at the FOV edges.

**Revised position for scenario (a):** If both sites use the same Siemens scanner model (e.g., both Prisma), B₁⁺ < 2% remains valid. If they use different Siemens models, add a "B₁⁺ caution" of up to 3-5%, particularly for vertex and cerebellar ROIs. This is still far below Agent C's cross-vendor 5-15%, but it should not be assumed zero.

**Recommendation for scenario (a):** Document scanner models at both sites. If they differ, acquire B₁⁺ maps at both sites. This is a low-cost insurance against a reviewer objection.

### 6.3 g-factor "hot spots" (max g ~5.0 for GE AIR 16ch prototype) — impact on scenario (a)'s R=2/R=3 decision

**Verdict: Agent C's finding does NOT change my recommendation for scenario (a).**

The max g ~5.0 reported by Ragan et al. (2021) for a prototype GE AIR 16ch coil reflects (a) the prototype nature of that coil, (b) flexible element positioning that can create unpredictable sensitivity gaps, and (c) the low channel count (16ch, not 20ch). None of these apply to scenario (a):

- Scenario (a)'s 20 elements are the densest, best-characterized subset of the Siemens 32ch array.
- Element positions are fixed in a known, optimized geometry.
- The 20-element subset has been characterized in the literature (Kaza 2011, de Zwart 2004).

**The GE AIR hot-spot finding is a cautionary tale for scenario (c), not scenario (a).** For scenario (a), R=2 is clearly safe; R=3 is viable for subcortical/temporal regions but requires g-factor documentation for dorsal ROIs.

### 6.4 "Prescan normalize is different per vendor" — does this matter for scenario (a)?

**Verdict: No — this does not apply to scenario (a).**

Agent C is correct that Siemens "Prescan Normalize," GE's variant, and Philips "CLEAR" are different algorithms. However, in scenario (a), both sites use the same Siemens scanner (or at minimum, the same vendor), and both use the "Prescan Normalize" filter from the Siemens ICE reconstruction pipeline. The algorithm is the same at both sites.

The scenario (a) concern is more subtle: the *interaction* of prescan normalize with the specific coil mode (20ch vs 32ch) may differ because the receive sensitivity profile differs. This is a **within-algorithm** effect that Schmitt 2021 partially characterizes for Siemens coils. It is not the **cross-algorithm** concern that Agent C raises.

**However**, I recognize that Agent C's point exposes an implicit assumption in my analysis: that both sites run the same software version (VB/VD/VE) of Siemens ICE. Different software versions can have subtle differences in prescan normalize implementation. **Updated recommendation for scenario (a):** Verify that both sites run the same software version and that the prescan normalize algorithm is identical. If software versions differ, this is a secondary confound that should be documented.

### 6.5 Traveling subjects: Agent C recommends 8-10 minimum vs Agent A's "helpful but not essential"

**Verdict: Agent C's 8-10 recommendation is appropriate for scenario (c), not for scenario (a). The discrepancy reflects genuinely different requirements.**

My scenario (a) assessment of "helpful but not essential" for traveling subjects is based on the following logic:
- The hardware bias is purely quantitative (fewer active channels, same elements), not qualitative.
- The spatial pattern of the bias is predictable (vertex > deep brain > temporal).
- Covariate-based correction + ComBat handles additive biases well.
- The literature provides direct quantitative guidance for the bias magnitude.

None of these conditions hold for scenario (c). Agent C's 8-10 recommendation is appropriate for their scenario's uncertainty level. If scenario (a) authors were to adopt Agent C's recommendation, it would be excessive — 3-5 traveling subjects would provide more than enough validation for scenario (a).

**Updated position:** I maintain "helpful but not essential" for scenario (a), but I add: if CAD Lab can afford traveling subjects, 3-5 is a worthwhile investment even for scenario (a), primarily to defend against the reviewer objection "this is all based on literature estimates, not local measurements."

### 6.6 Should scenario (a) adopt Agent C's "abandon pooling" recommendation?

**Verdict: No — Agent C's recommendation to abandon pooling is appropriate for scenario (c) conditions but would be premature for scenario (a).**

Agent C's "abandon pooling" criteria include:
1. No traveling subjects
2. Primary ROIs in dorsal PFC/superior parietal/occipital
3. Unequal group composition across sites
4. <15 sessions at one site
5. Unbalanced longitudinal design

For scenario (a), criteria (1) and (2) are less concerning because the SNR bias is better characterized and the literature provides direct quantitative guidance for correction. Criterion (2) is partially applicable (dorsal ROIs are affected), but the expected SNR loss is 40-55%, not the unbounded 40-60% uncertainty range of scenario (c). Criterion (4) (<15 sessions) is equally relevant — small-sample batches degrade ComBat performance in any scenario.

**However, I acknowledge that criteria (3) and (5) apply equally to all scenarios.** If group composition is confounded with site, or if longitudinal coil transitions are unbalanced, no amount of hardware similarity rescues the design. These criteria are design-level, not coil-level.

**Bottom line for scenario (a):** Abandon pooling only if criteria (3) or (5) apply, or if traveling subjects are unavailable AND the primary ROI is dorsal vertex where SNR₀ loss approaches 50-65%. Otherwise, proceed with ComBat + covariate modeling + sensitivity analysis.

### 6.7 Single most important point from Agent C that scenario (a) should adopt

**The B₁⁺ caveat refinement (Section 6.2 above).**

Agent C's most valuable contribution for scenario (a) is the reminder that **different scanner models within the same vendor have different body coils**. My scenario (a) analysis assumed the same body coil and declared B₁⁺ negligible. If the two sites use different Siemens scanner models (e.g., Prisma at Korea, Vida at US), then a 3-5% B₁⁺ differential could exist.

**Proactive action for scenario (a):** 
1. Document the exact scanner model at each site.
2. If different models, acquire B₁⁺ maps at both sites (a quick 30-second sequence).
3. Include B₁⁺ maps in the supplement to preempt the reviewer objection that Agent C correctly identified.

This is cheap insurance that addresses a concern that, while less severe for scenario (a) than (c), could nevertheless derail a review if raised.

---

## Section 7: Final Statement from Agent A

### Synthesis

The cross-verification exercise reveals a clear hierarchy: scenario (a) is the most defensible, scenario (b) is riskier but potentially salvageable, and scenario (c) is the most problematic — likely requiring the PI to either invest substantially in traveling subjects or abandon pooling altogether.

**Which scenarios can be rescued by which Must Fix items?**

Scenario (a) can be rescued by the existing Must Fix items from the Integration Report (MF1-MF11), with two additions from this cross-verification: (i) verify scanner model match and acquire B₁⁺ maps if they differ (adopted from Agent C's B₁⁺ concern), and (ii) measure or simulate g-factor maps for the lower-20 mode rather than relying solely on literature (adopted from Agent B's MF3 emphasis). The core argument — "same hardware, fewer channels" — remains viable with moderate harmonization (ComBat + covariate modeling + sensitivity analysis). Traveling subjects are helpful but not essential; 3-5 would suffice for validation.

Scenario (b) requires all MF1-MF11, but with larger effect sizes and tighter thresholds. The critical additional requirement is **traveling subjects** (minimum 5-6, per Agent B's recommendation). Without traveling subjects, the coil difference is too large and too poorly characterized for a NeuroImage-level defense. The detachable anterior component must be tracked as an additional degree of freedom. Schmitt 2021 provides partial support for the coil's data quality but does not validate cross-site pooling.

Scenario (c) faces the highest bar. The SNR₀ uncertainty of ±40-60%, the unknown g-factor behavior (including potential hot spots), the B₁⁺ differential of 5-15%, the different prescan normalize algorithms, and the different parallel imaging architectures (GRAPPA vs SENSE) combine to create a situation where harmonization methods operate in near-complete darkness. Scenario (c) requires all 11 original MF items plus the six additional items Agent C identified (MF12-MF17). Without traveling subjects (minimum 8-10), scenario (c) is effectively unpublishable at NeuroImage/HBM level. Even with traveling subjects, the risk of an irreproducible finding remains substantially higher than scenarios (a) or (b).

### The Single Most Important Hardware Determination

**The CAD Lab must determine, beyond reasonable doubt, which of the three scenarios actually describes the US site's coil.** This is MF2 ("Coil type determination") from the Integration Report, and this cross-verification exercise has demonstrated that the three scenarios lead to fundamentally different conclusions about publishability, required corrections, and harmonization strategy.

The specific determination needed: **Is the US site's 20-channel coil (a) a Siemens 32ch head coil operating in lower-20 mode, (b) a Siemens 20ch head/neck coil (different physical product), or (c) a non-Siemens 20ch coil (GE, Philips, or other)?**

If the answer is (a) → proceed with moderate corrections → NeuroImage viable.
If the answer is (b) → require traveling subjects + major corrections → NeuroImage possible but high risk.
If the answer is (c) → require traveling subjects + extensive validation → NeuroImage very high risk; consider lower-tier journal or abandon pooling.

**This determination should be made by:**
1. Reading the exact coil model number and part number from both scanners.
2. Examining physical photographs of the coils to verify soccer-ball geometry (32ch) vs neck-extension housing (20ch H/N) vs flexible cloth (GE AIR) vs different rigid shell (Philips dStream).
3. Contacting the Siemens/G.E./Philips applications specialist for the US site if model number is ambiguous.

### When to Advise Abandoning Inter-Site Pooling Altogether

As an MRI physicist, I would advise the PI to abandon inter-site pooling under the following conditions, ordered from most to least clear:

1. **Scenario (c) confirmed + no traveling-subject funding.** The SNR₀ uncertainty (±40-60%), unknown g-factor, and B₁⁺ differences make the bias too large and too poorly characterized for any harmonization method to reliably correct. The study would rest on untestable assumptions, and a NeuroImage reviewer will identify this immediately.

2. **Any scenario + clinical group imbalance across sites.** If Korea site has 80% controls and US site has 80% patients (or any similarly unbalanced design), the site+coil confound is inseparable from the clinical group label. No harmonization method can reliably separate hardware effects from biological effects in this case.

3. **Scenario (b) confirmed + no traveling subjects + primary ROIs include dorsal PFC/occipital.** The 55-70% SNR₀ loss and severe g-factor at R≥3 in these regions make reliable BOLD detection uncertain. Without traveling subjects to measure the actual bias, the study risks an irreproducible dorsal finding.

4. **Any scenario + <15 sessions at either site + ComBat as the primary harmonization method.** ComBat's empirical Bayes shrinkage requires ~20 scans per batch for stable estimates. With <15, ComBat may increase bias rather than reduce it. The sample is too small for the primary correction tool to function.

**The hardest case:** Scenario (a), with balanced groups, matched scanner models, ≥20 sessions per site, and with ComBat + covariate modeling + sensitivity analysis. This is the scenario where pooling remains viable, defensible, and — with the Must Fix items — publishable at the NeuroImage level.
